OncoAlert
@oncoalert
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
ID: 1109128247789395968
http://www.OncoAlert360.com 22-03-2019 16:22:35
95,95K Tweet
36,36K Followers
160 Following
Dear Colleagues, The OncoAlert 🚨Network Presents OUR Picks of TOP 🔟Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads Elisa Agostinetto 🇮🇹 Elisabetta Bonzano MD, PhD 🇮🇹 Luca Arecco, MD 🇮🇹 Gil Morgan, MD 🇺🇸 With our distinguished OncoAlert Faculty: Sara Tolaney
The Man Van: A pilot study of using mobile targeted case-finding to address health inequalities in prostate cancer out on International Journal of Cancer by Nick James and team onlinelibrary.wiley.com/doi/10.1002/ij… The Man Van 🚍project was developed to improve early detection of
Top 10 lung cancer abstracts #ESMO24 ESMO - Eur. Oncology by #OncoAlert ✅
🚨“Can’t-miss” lung cancer abstracts to be presented at #ESMO24! OncoAlert Hidehito HORINOUCHI Biagio Ricciuti, MD PhD Eric K. Singhi, MD Gil Morgan, MD
New study led by Dr Jacob Hogan of Harvard Radiation Oncology Residency Program explores how distance from treatment facilities & sociodemographic factors (race, income, insurance) impact radiotherapy recommendation, initiation, & completion for patients w/ cancer: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #radonc
How to optimize the treatment for #renalcancer in real world? Join us & discuss with Yüksel Ürün from Ankara Üniversitesi in presence or virtually! Register for free 👉 ow.ly/9SSw50TgqIr #IUCS24 #urology #oncology Giuseppe Banna Ravindran Kanesvaran
Our Dear friends the Oncology Brothers with🔟anticipated Practice changing Abstracts to be Presented at #ESMO24 !!
📊 Slides uploaded ✅ 👜 Packed ✅ 🤩 Excited for my first IASLC ✈️ See you in San Diego! #WCLC24 Oncology Nursing Society OncoAlert ISNCC ASCO PallOnc Community of Practice
🧬Mismatch repair in pancreatic cancer JAMA Oncology ✅Although it is rare, MSI should be tested in pancreatic cancer ✅Median IO duration: 27.7 months, DCR: 80% 👉doi:10.1001/jamaoncol.2024.3651 Catherine O’Connor Emily Harrold Wungki Park, MD MS Eileen M O’Reilly #cancer #Oncology #MedX
Out today in TIME — a review of recent advances in #KidneyCancer treatment highlighting the incredible work of Toni Choueiri, MD Dana-Farber Lank Center for Genitourinary Oncology Brian Rini, MD Vanderbilt Hem / Onc william huang nyulmc Katie Spina (she/her) Columbia RadOnc George R Schade Fred Hutchinson Cancer Center and many others! It takes a village to
🥁 Please to share our last work "Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer" Frontiers - Oncology KRASKickers OncoAlert #LCMS #PrecisionMedicine #LungCancer frontiersin.org/journals/oncol…